When was BioImage founded?

BioImage was founded in 1999 and raised its 1st funding round within a year of its incorporation.

Where is BioImage located?

BioImage is headquartered in Copenhagen, Denmark.

How many employees does BioImage have?

As of Sep 30, 2026, the latest employee count at BioImage is 7.

Is BioImage a funded company?

BioImage is a funded company, having raised a total of $30.5M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 28, 1999.

When was the latest funding round of BioImage?

BioImage's latest funding was a $***** Series B round on Jan 23, 2002, with participation from 3 investors. Its primary sector is Life Sciences Platforms and Tools. Globally, the Life Sciences Platforms and Tools sector has seen $2.49B in funding in 2026 to date.

Where does BioImage rank among its competitors?

BioImage ranks 6th amongst 17 active competitors, of which 6 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was HAWK Biosystems, which secured $3.93M in Oct, 2026.

Who are the top competitors of BioImage?

BioImage's top competitors include Araceli Biosciences, ACD and Lodestone Biomedical. Among them, HAWK Biosystems secured the most recent funding round in October, 2026.

BioImage - 2026 Company Profile, Team, Funding & Competitors

BioImage is an acqui-hired company based in Copenhagen (Denmark), founded in 1999 by Fuhui Long, Ole Thastrup and Tamar Blumenfeld-katzir. It operates as a Developer of bioassays for biopharmaceutical companies and research institutions. BioImage has raised $30.5M in funding. The company has 17 active competitors, including 6 funded and 1 that has exited. Its top competitors include companies like Araceli Biosciences, ACD and Lodestone Biomedical.

Company Details

Developer of bioassays for biopharmaceutical companies and research institutions. BioImage specialized in developing and selling proprietary bioassays to biopharmaceutical companies and research institutions. It also developed bioassays on a contract service basis. BioImage had broad patents covering Enhanced GFP (EGFP), GFP-based biosensors, and any genetically encoded protein fusion to a luminophore, with subsequent monitoring of the protein's translocation within a cell as the primary readout for drug discovery assays. This intellectual property, trademarked Redistribution was the source of collaborations and out-licensing activities with biopharmaceutical companies.

Key Metrics

Founded Year

1999

Location

Copenhagen, Denmark

Stage

Acqui-Hired

Total Funding

$30.5M in 2 rounds

Latest Funding Round

Series B, Jan 23, 2002, $*****

Investors

Abingworth & 4 more

Ranked

6^th among 17 active competitors

Employee Count

7 as on Sep 30, 2026

Similar Companies

Araceli Biosciences & 18 more

View BioImage's full profile

BioImage has raised a total funding of $30.5M over 2 rounds. Its first funding round was on Apr 28, 1999. Its latest funding round was a Series B round on Jan 23, 2002 for $*****. 3 investors participated in its latest round. BioImage has 5 institutional investors.

Here is the list of recent funding rounds of BioImage:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 23, 2002	7598367	Series B	7457944	8815475	7445259	1322088
Apr 28, 1999	6015499	Series A	4890421	6165815	3915363	Apax & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of BioImage's funding rounds and investors

The founders of BioImage are Fuhui Long, Ole Thastrup and Tamar Blumenfeld-katzir.

Here are the details of BioImage's key team members:

Fuhui Long: Co-Founder of BioImage.
Ole Thastrup: Co-Founder of BioImage.
Tamar Blumenfeld-katzir: Co-Founder of BioImage.

View details of BioImage's Founder profiles and Board Members

BioImage's employee count trend

BioImage has 7 employees as of Sep 26. Here is BioImage's employee count trend over the years:

Uncover BioImage's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioImage include Araceli Biosciences, ACD and Lodestone Biomedical. Here is the list of Top 10 competitors of BioImage, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Araceli Biosciences 2020, United States, Seed	Developer of scientific tools for tissue and cell-based biomarker discovery & drug development	$25.7M	-	55/100
2nd	ACD 2006, Newark (United States), Acquired	Developer of a transnational research platform for biomarker analysis	$39.4M	Summit Partners, Morningside & 5 others	49/100
3rd	Lodestone Biomedical 2015, Hanover (United States), Seed	Provider of magnetic nanoparticle platform technology for in vivo biomarker monitoring in immuno-oncology	$1.18M	MassChallenge, Dartmouth Regional Technology Center ... Read more	41/100
4th	HAWK Biosystems 2015, Derio (Spain), Series A	Developer of clinical assays for quantifying novel biomarkers	$3.93M	Inveready, EIC Fund & 3 others	37/100
5th	BioAmp Diagnostics 2017, Berkeley (United States), Seed	Developers of diagnostic tests that help to treat patient with a specific antibiotic	-	Illumina, CITRIS Foundry & 8 others	36/100
6th	BioImage 1999, Copenhagen (Denmark), Acqui-Hired	Developer of bioassays for biopharmaceutical companies and research institutions	$30.5M	Abingworth, Novo Holdings & 3 others	30/100
7th	Haga Bio Science Solna (Sweden), Seed	Developer of spatial RNA detection assays for clinical biomarker validation	$2.3M	Almi Invest, Almi & 1 others	28/100
8th	Cellkey 2019, Cheongju (South Korea), Unfunded	Provider of AI-driven multiomics data analysis and biomarker discovery solutions	-	-	24/100
9th	Phoenix Biosystem 2001, Serpentine (Australia), Funding Raised	Developer of biomarker panels and assays for disease assessment and detection	-	National Science Foundation, HHS	24/100
10th	ThinkSense 2004, Mclean (United States), Unfunded	A company that provides AI & data-driven digital biomarker technology solutions for clinical trials	-	-	24/100